{"id":348277,"date":"2026-11-16T12:56:41","date_gmt":"2026-11-16T07:26:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=348277"},"modified":"2026-11-16T12:56:41","modified_gmt":"2026-11-16T07:26:41","slug":"why-invicta-diagnostic-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/","title":{"rendered":"Invicta Diagnostic (INVICTA) Share Price Falls 10.12% to Rs 74.60: Price Action, Fundamentals and Sector View"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em>Invicta Diagnostic (INVICTA) share price fell to Rs 74.6 today, down 10.12% from the previous close. Market cap was Rs 104.35 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\"><strong>Invicta Diagnostic Share Price<\/strong> fell 10.12% on 16 November 2026, with the stock last trading at Rs 74.60 against a previous close of Rs 83.00 as of 16 November 2026 at 12:53:04 PM IST. The decline of Rs 8.40 leaves Invicta Diagnostic, a Micro Cap company in the Hospital &#038; Healthcare Services industry, with a market capitalisation of Rs 104.35 crore.<\/p>\n<p>The stock opened at Rs 78.20, below its previous close, touched a high of Rs 78.25 and has since slid to a low of Rs 74.60, which is also its current price. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The Invicta Diagnostic share price news today is therefore about the size of the move and the verified numbers behind it.<\/p>\n<p>The key metrics are a P\/E ratio of 21.27, a P\/B ratio of 2.06, ROE of 14.93% and ROCE of 19.88%. Next, investors can monitor whether the Invicta Diagnostic stock holds above the day&#8217;s low, how its fundamentals compare with the Hospital &#038; Healthcare Services benchmark, and any company announcement that follows.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#Invicta_Diagnostic_INVICTA_Share_Price_Today_Price_Action_Analysis\" title=\"Invicta Diagnostic (INVICTA) Share Price Today: Price Action Analysis\">Invicta Diagnostic (INVICTA) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#Invicta_Diagnostic_INVICTA_Fundamental_Analysis\" title=\"Invicta Diagnostic (INVICTA) Fundamental Analysis\">Invicta Diagnostic (INVICTA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Invicta_Diagnostic\" title=\"Why Investors Are Watching Invicta Diagnostic\">Why Investors Are Watching Invicta Diagnostic<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#About_Invicta_Diagnostic\" title=\"About Invicta Diagnostic\">About Invicta Diagnostic<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#Track_Invicta_Diagnostic_Share_Price_on_Univest\" title=\"Track Invicta Diagnostic Share Price on Univest\">Track Invicta Diagnostic Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#Why_is_Invicta_Diagnostic_share_price_falling_today\" title=\"Why is Invicta Diagnostic share price falling today?\">Why is Invicta Diagnostic share price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#What_is_the_Invicta_Diagnostic_share_price_today\" title=\"What is the Invicta Diagnostic share price today?\">What is the Invicta Diagnostic share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#What_is_the_market_capitalisation_of_Invicta_Diagnostic\" title=\"What is the market capitalisation of Invicta Diagnostic?\">What is the market capitalisation of Invicta Diagnostic?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#What_is_the_PE_ratio_of_Invicta_Diagnostic\" title=\"What is the P\/E ratio of Invicta Diagnostic?\">What is the P\/E ratio of Invicta Diagnostic?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#What_are_the_ROE_and_ROCE_of_Invicta_Diagnostic\" title=\"What are the ROE and ROCE of Invicta Diagnostic?\">What are the ROE and ROCE of Invicta Diagnostic?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#What_are_the_EPS_and_book_value_of_Invicta_Diagnostic\" title=\"What are the EPS and book value of Invicta Diagnostic?\">What are the EPS and book value of Invicta Diagnostic?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#Does_Invicta_Diagnostic_pay_a_dividend\" title=\"Does Invicta Diagnostic pay a dividend?\">Does Invicta Diagnostic pay a dividend?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#How_does_Invicta_Diagnostic_compare_with_its_peers\" title=\"How does Invicta Diagnostic compare with its peers?\">How does Invicta Diagnostic compare with its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-invicta-diagnostic-share-price-fall-today-2026\/#What_should_investors_monitor_in_Invicta_Diagnostic_stock_news\" title=\"What should investors monitor in Invicta Diagnostic stock news?\">What should investors monitor in Invicta Diagnostic stock news?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_INVICTA_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Invicta Diagnostic (INVICTA) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 74.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 83<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 8.40 (-10.12%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 78.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 78.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 74.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 104.35 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Micro Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Invicta Diagnostic share price today<\/strong> is Rs 74.60, down Rs 8.40 or 10.12% from the previous close of Rs 83.00. The session began with a gap lower, as trading opened at Rs 78.20, which is Rs 4.80 below the previous close, and the stock has kept falling since.<\/p>\n<p>The day&#8217;s range runs from Rs 74.60 to Rs 78.25, a spread of Rs 3.65. The intraday high of Rs 78.25 is only Rs 0.05 above the opening price, so buyers had little room above the open before the decline resumed. The price is now Rs 3.60 below the opening level.<\/p>\n<p>As of 12:53 PM IST, the stock sits exactly at the day&#8217;s low of Rs 74.60 and Rs 3.65 below the day&#8217;s high. This is where the <strong>Invicta Diagnostic share price update<\/strong> places the stock inside its range, and it is the level to compare against as the session continues.<\/p>\n<p>Invicta Diagnostic is classified as a Micro Cap company, and its market capitalisation stands at Rs 104.35 crore. Market capitalisation indicates company size, not quality, so it frames the scale of the business rather than the reason for the <strong>Invicta Diagnostic share price fall<\/strong> seen today. The price action is clear, and the next step is to read the fundamentals behind it.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_INVICTA_Fundamental_Analysis\"><\/span><strong>Invicta Diagnostic (INVICTA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 104.35 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.06x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.93%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.88%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 40.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Invicta Diagnostic (INVICTA) fundamental metrics show P\/E 21.27x, P\/B 2.06x, ROE 14.93%, ROCE 19.88%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Invicta Diagnostic has a market capitalisation of Rs 104.35 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 21.27x, P\/B at 2.06x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.93% and ROCE of 19.88%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.9, book value per share of Rs 40.3, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 44.34x, median ROE of 12.88%, median ROCE of 15.43%. Taken together, they outline the fundamentals rather than a view on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Hospital &amp; Healthcare Services<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.34x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">74.75x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.09x to 755.5x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.06x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.03x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.93%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.88%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.88%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.55%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 104.35 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 583.5 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 10,761.21 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Invicta Diagnostic (INVICTA) operates in the Healthcare sector, within the Hospital &amp; Healthcare Services industry.<\/p>\n<p>Invicta Diagnostic (INVICTA) has a P\/E ratio of 21.27x, which is below the benchmark median of 44.34x, a difference of -52.03%. On its own, the P\/E gap is a valuation reference point, not a trading call.<\/p>\n<p>Invicta Diagnostic (INVICTA) has a ROE of 14.93%, which is above the benchmark median of 12.88%, a difference of +15.92%. Invicta Diagnostic (INVICTA) has a ROCE of 19.88%, which is above the benchmark median of 15.43%, a difference of +28.84%.<\/p>\n<p>Track stocks among today&#39;s decliners through the <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/apollohosp\/apollo-hospitals-enterprise-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Apollo Hospitals Enterprise<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">APOLLOHOSP<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,22,439.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">54.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.73<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/maxhealth\/max-healthcare-institute-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Max Healthcare Institute<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MAXHEALTH<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">91,979.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">66.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/manipalhos\/manipal-health-enterpri-l-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>MANIPAL HEALTH ENTERPRI L<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MANIPALHOS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">89,445.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">100.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.93<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/asterdm\/aster-dm-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aster DM Healthcare<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ASTERDM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62,952.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">133.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.46<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.22<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fortis\/fortis-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Fortis Healthcare<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">FORTIS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">57,754.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">55.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.07<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Invicta Diagnostic (INVICTA) has a P\/E ratio of 21.27x compared with the displayed peer median of 66.62x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 14.93% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 19.88% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Invicta Diagnostic (INVICTA) has a market capitalisation of Rs 104.35 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Invicta_Diagnostic\"><\/span><strong>Why Investors Are Watching Invicta Diagnostic<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Price action: the stock opened Rs 4.80 below its previous close and fell a total of Rs 8.40 per share, trading at the day&#8217;s low of Rs 74.60.<\/li>\n<li>Valuation: the P\/E ratio of 21.27 and P\/B ratio of 2.06 are both below the Hospital &#038; Healthcare Services benchmark medians.<\/li>\n<li>Returns: ROE of 14.93% and ROCE of 19.88% are both above the benchmark medians.<\/li>\n<li>Size: a Micro Cap market capitalisation of Rs 104.35 crore, below the sector median of Rs 583.50 crore.<\/li>\n<li>Per-share data: EPS of Rs 3.90, book value of Rs 40.30 and a dividend yield of 0%.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Invicta_Diagnostic\"><\/span><strong>About Invicta Diagnostic<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Invicta Diagnostic is a listed company in the Healthcare sector and the Hospital &#038; Healthcare Services industry, and it is classified as a Micro Cap. It is one of 67 companies in the same-industry benchmark, where its market capitalisation of Rs 104.35 crore is below the median of Rs 583.50 crore.<\/p>\n<p>Hospital &#038; Healthcare Services is the group against which its P\/E, P\/B, ROE and ROCE are measured, and Apollo Hospitals Enterprise, Max Healthcare Institute and Manipal Health Enterprises are among the larger listed names in it. This sector context frames the company&#8217;s financial ratios and the Invicta Diagnostic stock performance today.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Invicta_Diagnostic_Share_Price_on_Univest\"><\/span><strong>Track Invicta Diagnostic Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Readers can follow the live Invicta Diagnostic share price on Univest, along with fundamental ratios such as the P\/E ratio, P\/B ratio, ROE and ROCE, 52-week levels and wider market insights. Univest also lets users compare Invicta Diagnostic with sector peers and review the Healthcare group in one place, so the share price and the numbers behind it stay together.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Invicta_Diagnostic_share_price_falling_today\"><\/span><strong>Why is Invicta Diagnostic share price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The Invicta Diagnostic share price fell 10.12% to Rs 74.60 from a previous close of Rs 83.00.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Invicta_Diagnostic_share_price_today\"><\/span><strong>What is the Invicta Diagnostic share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;As of 12:53 PM IST, the Invicta Diagnostic share price is Rs 74.60, down Rs 8.40 from the previous close of Rs 83.00, with a day high of Rs 78.25 and a day low of Rs 74.60.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Invicta_Diagnostic\"><\/span><strong>What is the market capitalisation of Invicta Diagnostic?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The Invicta Diagnostic share price reflects a market capitalisation of Rs 104.35 crore, a Micro Cap. That is below the sector benchmark median of Rs 583.50 crore and the average of Rs 10,761.21 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Invicta_Diagnostic\"><\/span><strong>What is the P\/E ratio of Invicta Diagnostic?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;At a P\/E ratio of 21.27, the Invicta Diagnostic share price is valued below the sector benchmark median of 44.34 and the average of 74.75, based on 58 companies with a reported P\/E ratio.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_ROE_and_ROCE_of_Invicta_Diagnostic\"><\/span><strong>What are the ROE and ROCE of Invicta Diagnostic?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Invicta Diagnostic reports ROE of 14.93% and ROCE of 19.88%. The sector benchmark median is 12.88% for ROE and 15.43% for ROCE, so both company figures are above the sector median.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_EPS_and_book_value_of_Invicta_Diagnostic\"><\/span><strong>What are the EPS and book value of Invicta Diagnostic?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Invicta Diagnostic reports EPS of Rs 3.90 and a book value of Rs 40.30 per share. With a P\/B ratio of 2.06, the Invicta Diagnostic share price of Rs 74.60 sits above book value per share.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_Invicta_Diagnostic_pay_a_dividend\"><\/span><strong>Does Invicta Diagnostic pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The dividend yield for Invicta Diagnostic is 0%. Dividend yield is historical and current data, not a promise of future payouts, and it is measured against the Invicta Diagnostic share price of Rs 74.60.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Invicta_Diagnostic_compare_with_its_peers\"><\/span><strong>How does Invicta Diagnostic compare with its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Its P\/E ratio of 21.27 and P\/B ratio of 2.06 are below all five peers. Its ROE of 14.93% is above four of them and below only Apollo Hospitals Enterprise at 23.54%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_in_Invicta_Diagnostic_stock_news\"><\/span><strong>What should investors monitor in Invicta Diagnostic stock news?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Investors can monitor company announcements, whether the price holds above the day&#39;s low of Rs 74.60 and how it trades against the previous close of Rs 83.00, and how the P\/E and P\/B ratios compare with the sector benchmark.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is Invicta Diagnostic share price falling today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The Invicta Diagnostic share price fell 10.12% to Rs 74.60 from a previous close of Rs 83.00.\"}},{\"@type\":\"Question\",\"name\":\"What is the Invicta Diagnostic share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 12:53 PM IST, the Invicta Diagnostic share price is Rs 74.60, down Rs 8.40 from the previous close of Rs 83.00, with a day high of Rs 78.25 and a day low of Rs 74.60.\"}},{\"@type\":\"Question\",\"name\":\"What is the market capitalisation of Invicta Diagnostic?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Invicta Diagnostic share price reflects a market capitalisation of Rs 104.35 crore, a Micro Cap. That is below the sector benchmark median of Rs 583.50 crore and the average of Rs 10,761.21 crore.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Invicta Diagnostic?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"At a P\/E ratio of 21.27, the Invicta Diagnostic share price is valued below the sector benchmark median of 44.34 and the average of 74.75, based on 58 companies with a reported P\/E ratio.\"}},{\"@type\":\"Question\",\"name\":\"What are the ROE and ROCE of Invicta Diagnostic?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Invicta Diagnostic reports ROE of 14.93% and ROCE of 19.88%. The sector benchmark median is 12.88% for ROE and 15.43% for ROCE, so both company figures are above the sector median.\"}},{\"@type\":\"Question\",\"name\":\"What are the EPS and book value of Invicta Diagnostic?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Invicta Diagnostic reports EPS of Rs 3.90 and a book value of Rs 40.30 per share. With a P\/B ratio of 2.06, the Invicta Diagnostic share price of Rs 74.60 sits above book value per share.\"}},{\"@type\":\"Question\",\"name\":\"Does Invicta Diagnostic pay a dividend?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The dividend yield for Invicta Diagnostic is 0%. Dividend yield is historical and current data, not a promise of future payouts, and it is measured against the Invicta Diagnostic share price of Rs 74.60.\"}},{\"@type\":\"Question\",\"name\":\"How does Invicta Diagnostic compare with its peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Its P\/E ratio of 21.27 and P\/B ratio of 2.06 are below all five peers. Its ROE of 14.93% is above four of them and below only Apollo Hospitals Enterprise at 23.54%.\"}},{\"@type\":\"Question\",\"name\":\"What should investors monitor in Invicta Diagnostic stock news?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors can monitor company announcements, whether the price holds above the day's low of Rs 74.60 and how it trades against the previous close of Rs 83.00, and how the P\/E and P\/B ratios compare with the sector benchmark.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Invicta Diagnostic Share Price fell 10.12% to Rs 74.60 today. Market cap stands at Rs 104.35 crore.<\/p>\n","protected":false},"author":35,"featured_media":348276,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-348277","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["348276"],"rank_math_title":["Invicta Diagnostic Share Price Falls 10.12%: Analysis"],"rank_math_description":["Invicta Diagnostic Share Price fell 10.12% to Rs 74.60. See price action, fundamental analysis, Healthcare sector context and a peer comparison on Univest."],"rank_math_focus_keyword":["Invicta Diagnostic Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/Invicta_Diagnostic_INVICTA_Share_Price_Falls_1012_to_Rs_7460_Price_Action_Fundamentals_and_Sector_View_bearish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348277","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=348277"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348277\/revisions"}],"predecessor-version":[{"id":348278,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348277\/revisions\/348278"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/348276"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=348277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=348277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=348277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}